Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (241-250 of 760) with videos related to

Pageof 76
Sort By:
Interventional Cardiology Clinics|December 14, 2024
Switching Platelet P2Y<sub>12</sub> Receptor Inhibiting TherapiesLuis Ortega-Paz, Fabiana Rollini, Francesco Franchi, et al.
Journal of the American College of Cardiology|December 8, 2018
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline ComparisonDavide Capodanno, Fernando Alfonso, Glenn N Levine, et al.
The American Journal of Cardiology|September 9, 2008
Prognostic significance of troponin T elevation in patients without chest painErik R Carlson, Robert F Percy, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Interventions|April 16, 2024
Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary InterventionAlessandro Spirito, Sriya L Krishnan, Davide Capodanno, et al.
Journal of the American College of Cardiology|November 19, 2013
Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events)José L Ferreiro, Deepak L Bhatt, Masafumi Ueno, et al.
Journal of Thrombosis and Thrombolysis|February 14, 2021
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelorDominick J Angiolillo, Latonya Been, Marc Rubinstein, et al.
European Journal of Pharmacology|September 6, 2015
Drug-drug interactions between clopidogrel and novel cardiovascular drugsFrancesco Pelliccia, Fabiana Rollini, Giuseppe Marazzi, et al.
Expert Review of Cardiovascular Therapy|October 22, 2013
Cangrelor: a review on pharmacology and clinical trial developmentFrancesco Franchi, Fabiana Rollini, Ana Muñiz-Lozano, et al.
Journal of the American College of Cardiology|October 23, 2024
Aspirin Hypersensitivity in Patients With Atherosclerotic Cardiovascular DiseaseMattia Galli, Gabriele Cortellini, Giovanni Occhipinti, et al.
Journal of the American College of Cardiology|April 25, 2015
Reply: elevated serum fibrinogen: an independent link between diabetes mellitus, impaired on-clopidogrel platelet inhibition, and major adverse cardiac events after percutaneous coronary interventionDominick J Angiolillo, Joseph A Jakubowski, Francesco Franchi, et al.
Pageof 76

Showing results (241-250 of 760) with videos related to

Sort By:
Pageof 76
Interventional Cardiology Clinics|December 14, 2024
Switching Platelet P2Y<sub>12</sub> Receptor Inhibiting TherapiesLuis Ortega-Paz, Fabiana Rollini, Francesco Franchi, et al.
Journal of the American College of Cardiology|December 8, 2018
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline ComparisonDavide Capodanno, Fernando Alfonso, Glenn N Levine, et al.
The American Journal of Cardiology|September 9, 2008
Prognostic significance of troponin T elevation in patients without chest painErik R Carlson, Robert F Percy, Dominick J Angiolillo, et al.
Circulation. Cardiovascular Interventions|April 16, 2024
Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary InterventionAlessandro Spirito, Sriya L Krishnan, Davide Capodanno, et al.
Journal of the American College of Cardiology|November 19, 2013
Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events)José L Ferreiro, Deepak L Bhatt, Masafumi Ueno, et al.
Journal of Thrombosis and Thrombolysis|February 14, 2021
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelorDominick J Angiolillo, Latonya Been, Marc Rubinstein, et al.
European Journal of Pharmacology|September 6, 2015
Drug-drug interactions between clopidogrel and novel cardiovascular drugsFrancesco Pelliccia, Fabiana Rollini, Giuseppe Marazzi, et al.
Expert Review of Cardiovascular Therapy|October 22, 2013
Cangrelor: a review on pharmacology and clinical trial developmentFrancesco Franchi, Fabiana Rollini, Ana Muñiz-Lozano, et al.
Journal of the American College of Cardiology|October 23, 2024
Aspirin Hypersensitivity in Patients With Atherosclerotic Cardiovascular DiseaseMattia Galli, Gabriele Cortellini, Giovanni Occhipinti, et al.
Journal of the American College of Cardiology|April 25, 2015
Reply: elevated serum fibrinogen: an independent link between diabetes mellitus, impaired on-clopidogrel platelet inhibition, and major adverse cardiac events after percutaneous coronary interventionDominick J Angiolillo, Joseph A Jakubowski, Francesco Franchi, et al.
Pageof 76